Listen "Tryp Therapeutics"
Episode Synopsis
Tryp Therapeutics (OTCQB: TRYPF) is a pharmaceutical company focused on identifying and developing clinical-stage compounds for the treatment of rare and other diseases with high unmet medical needs through regulatory pathways. CEO Gregory McKee joins us to discuss the current progress the company has had with scientific collaborations and clinical activities. View Podcast Transcript for Tryp Therapeutics
More episodes of the podcast OTCQB Podcast
Cytta Corp.
12/01/2026
DarkPulse, Inc.
05/01/2026
Q2 Metals Corp.
08/12/2025
Zoomcar Holdings, Inc.
01/12/2025
Scorpio Gold Corp.
24/11/2025
Stuhini Exploration Ltd.
17/11/2025
Dotz Nano Ltd.
10/11/2025
District Metals Corp.
03/11/2025
Banyan Gold Corp.
27/10/2025
Brixton Metals Corp.
20/10/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.